BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 17928059)

  • 61. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.
    Rao DD; Senzer N; Cleary MA; Nemunaitis J
    Cancer Gene Ther; 2009 Nov; 16(11):807-9. PubMed ID: 19713999
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [MiRNA in disease and therapeutic development].
    Tanaka Y; Kozu T
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2509-14. PubMed ID: 17471971
    [No Abstract]   [Full Text] [Related]  

  • 63. Inhibition of the microRNA pathway in zebrafish by siRNA.
    Fjose A; Zhao XF
    Methods Mol Biol; 2010; 629():239-55. PubMed ID: 20387153
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [RNA interference: biology and perspectives of application in biomedicine and biotechnology].
    Vil'gel'm AE; Chumakov SP; Prasolov VS
    Mol Biol (Mosk); 2006; 40(3):387-403. PubMed ID: 16813159
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Emerging use of non-viral RNA interference in the brain.
    Cryan JF; Thakker DR; Hoyer D
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):411-5. PubMed ID: 17371288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function?
    Mattes J; Yang M; Foster PS
    Am J Respir Cell Mol Biol; 2007 Jan; 36(1):8-12. PubMed ID: 16917074
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The emerging therapeutic role of RNA interference in disorders of the central nervous system.
    Dessy A; Gorman JM
    Clin Pharmacol Ther; 2011 Mar; 89(3):450-4. PubMed ID: 21248728
    [No Abstract]   [Full Text] [Related]  

  • 68. Revealing the world of RNA interference.
    Mello CC; Conte D
    Nature; 2004 Sep; 431(7006):338-42. PubMed ID: 15372040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes.
    Fitzgerald K
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):557-66. PubMed ID: 16159017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Application of functional RNAs in human diseases].
    Tanaka Y; Kozu T
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2235-7. PubMed ID: 17471945
    [No Abstract]   [Full Text] [Related]  

  • 71. Role and therapeutic potential of microRNAs in diabetes.
    Kolfschoten IG; Roggli E; Nesca V; Regazzi R
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():118-29. PubMed ID: 19817794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The use of small interfering RNA to elucidate the activity and function of ion channel genes in an intact tissue.
    Gurney AM; Hunter E
    J Pharmacol Toxicol Methods; 2005; 51(3):253-62. PubMed ID: 15862470
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Small molecules in an RNAi world.
    Eggert US; Field CM; Mitchison TJ
    Mol Biosyst; 2006 Feb; 2(2):93-6. PubMed ID: 16880926
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research.
    Chang H
    Cancer Gene Ther; 2007 Aug; 14(8):677-85. PubMed ID: 17541422
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic potential of RNA interference for neurological disorders.
    Sah DW
    Life Sci; 2006 Oct; 79(19):1773-80. PubMed ID: 16815477
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expanding RNA physiology: microRNAs in a unicellular organism.
    Siomi H; Siomi MC
    Genes Dev; 2007 May; 21(10):1153-6. PubMed ID: 17504934
    [No Abstract]   [Full Text] [Related]  

  • 77. RNA interference as a gene knockdown technique.
    Shan G
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1243-51. PubMed ID: 19442757
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rapid conditional knock-down-knock-in system for mammalian cells.
    Hölzel M; Rohrmoser M; Orban M; Hömig C; Harasim T; Malamoussi A; Gruber-Eber A; Heissmeyer V; Bornkamm G; Eick D
    Nucleic Acids Res; 2007; 35(3):e17. PubMed ID: 17169998
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chemogenomics approaches to novel target discovery.
    Gaither LA
    Expert Rev Proteomics; 2007 Jun; 4(3):411-9. PubMed ID: 17552925
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RNA interference: hitting the on switch.
    Check E
    Nature; 2007 Aug; 448(7156):855-8. PubMed ID: 17713502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.